ChemicalBook >> CAS DataBase List >>4-oxo-27-TBDMS Withaferin A
4-oxo-27-TBDMS Withaferin A
- CAS No.
- 1214886-31-3
- Chemical Name:
- 4-oxo-27-TBDMS Withaferin A
- Synonyms
- 4-oxo-27-TBDMS Withaferin A;(5β,6β,22R)-27-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5,6-epoxy-22-hydroxy-1,4-dioxo-ergosta-2,24-dien-26-oic acid, δ-lactone;Ergosta-2,24-dien-26-oic acid, 27-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5,6-epoxy-22-hydroxy-1,4-dioxo-, δ-lactone, (5β,6β,22R)-
- CBNumber:
- CB85540932
- Molecular Formula:
- C34H50O6Si
- Molecular Weight:
- 582.85
- MDL Number:
- MOL File:
- 1214886-31-3.mol
Last updated:2023-06-08 09:03:09
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS02,GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H225-H319 | |||||||||
Precautionary statements | P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P337+P313-P370+P378-P403+P235-P501 | |||||||||
NFPA 704 |
|
4-oxo-27-TBDMS Withaferin A price More Price(3)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 28323 | 4-oxo-27-TBDMS Withaferin A | 1214886-31-3 | 1mg | $81 | 2024-03-01 | Buy |
Cayman Chemical | 28323 | 4-oxo-27-TBDMS Withaferin A | 1214886-31-3 | 10mg | $396 | 2024-03-01 | Buy |
Cayman Chemical | 28323 | 4-oxo-27-TBDMS Withaferin A | 1214886-31-3 | 5mg | $238 | 2024-03-01 | Buy |
4-oxo-27-TBDMS Withaferin A Chemical Properties,Uses,Production
Description
4-oxo-27-TBDMS Withaferin A is a derivative of the steroidal lactone withaferin A that has anticancer activity.1 It is cytotoxic to A2780 ovarian cancer cells (IC50 = 17 μM) but not to carboplatin-resistant A2780 (A2780/CP70) cells (IC50 = >100 μM). It is selective for A2780 cells over non-cancerous ARPE19 cells (IC50 = 1,660 μM). 4-oxo-27-TBDMS Withaferin A induces DNA fragmentation in A2780 cells.
References
1. Perestelo, N.R., Llanos, G.G., Reyes, C.P., et al. Expanding the chemical space of withaferin A by incorporating silicon to improve its clinical potential on human ovarian carcinoma cells J. Med. Chem. 62(9),4571-4585(2019).
4-oxo-27-TBDMS Withaferin A Preparation Products And Raw materials
Raw materials
Preparation Products
4-oxo-27-TBDMS Withaferin A Suppliers
Global( 8)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Shanghai Hongye Biotechnology Co. Ltd | 400-9205774 | sales@glpbio.cn | China | 6870 | 58 |
ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11289 | 58 |
Changzhou Furuisi Biotechnology Co., Ltd | 0519-85524369 | 3477467573@qq.com | China | 8618 | 58 |
Beijing Biocreative Technology Co., Ltd. | 15522676233 | 3007606172@qq.com | China | 1249 | 58 |
Shanghai Yiyan Biotechnology Co. , Ltd. | 021-69985186 13611928337 | 3427709316@qq.com | China | 7984 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 8740 | 58 |
TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.com | China | 24246 | 58 |
4-oxo-27-TBDMS Withaferin A
Ergosta-2,24-dien-26-oic acid, 27-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5,6-epoxy-22-hydroxy-1,4-dioxo-, δ-lactone, (5β,6β,22R)-
(5β,6β,22R)-27-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5,6-epoxy-22-hydroxy-1,4-dioxo-ergosta-2,24-dien-26-oic acid, δ-lactone
1214886-31-3